Assessing The Benefits Of Science In Terms Of Dollars And Sense

The United States Congress has a lot to worry about these days, such as massive budget deficits and signs of an impending economic recession. One thing Congress apparently is not very worried about is sustaining an adequate level of support for scientific research. But it should worry, because of the economic impact of R&D on the U.S. economy. Nobelist Leon Lederman, president-elect of AAAS, recently discussed the science funding crisis in an address before the Science Policy Association at t

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The United States Congress has a lot to worry about these days, such as massive budget deficits and signs of an impending economic recession. One thing Congress apparently is not very worried about is sustaining an adequate level of support for scientific research. But it should worry, because of the economic impact of R&D on the U.S. economy.

Nobelist Leon Lederman, president-elect of AAAS, recently discussed the science funding crisis in an address before the Science Policy Association at the New York Academy of Sciences. In providing strong evidence of the decline in American support of "little science," he referred to studies by Edwin Mansfield, a University of Pennsylvania economist whose work on the economic impact of basic research I've long admired.

Mansfield's studies support the conclusion that scientific research has a significant and direct impact on the economy, accounting for a large portion of U.S. economic growth and productivity. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies